These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
884 related articles for article (PubMed ID: 28279820)
1. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides. Modi V; Sankararamakrishnan R J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820 [TBL] [Abstract][Full Text] [Related]
2. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent. Modi V; Lama D; Sankararamakrishnan R J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956 [TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics study of segment peptides of Bax, Bim, and Mcl-1 BH3 domain of the apoptosis-regulating proteins bound to the anti-apoptotic Mcl-1 protein. Zhao RN; Fan S; Han JG; Liu G J Biomol Struct Dyn; 2015; 33(5):1067-81. PubMed ID: 24865469 [TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics simulations of pro-apoptotic BH3 peptide helices in aqueous medium: relationship between helix stability and their binding affinities to the anti-apoptotic protein Bcl-X(L). Lama D; Sankararamakrishnan R J Comput Aided Mol Des; 2011 May; 25(5):413-26. PubMed ID: 21523491 [TBL] [Abstract][Full Text] [Related]
5. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations. Lama D; Sankararamakrishnan R Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209 [TBL] [Abstract][Full Text] [Related]
6. Computational Design of BH3-Mimetic Peptide Inhibitors That Can Bind Specifically to Mcl-1 or Bcl-X Reddy CN; Manzar N; Ateeq B; Sankararamakrishnan R Biochemistry; 2020 Nov; 59(45):4379-4394. PubMed ID: 33146015 [TBL] [Abstract][Full Text] [Related]
7. Binding modes of Bcl-2 homology 3 (BH3) peptides with anti-apoptotic protein A1 and redesign of peptide inhibitors: a computational study. Chen Y; Wang J; Zhang J; Wang W J Biomol Struct Dyn; 2018 Nov; 36(15):3967-3977. PubMed ID: 29137527 [TBL] [Abstract][Full Text] [Related]
8. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Chen L; Willis SN; Wei A; Smith BJ; Fletcher JI; Hinds MG; Colman PM; Day CL; Adams JM; Huang DC Mol Cell; 2005 Feb; 17(3):393-403. PubMed ID: 15694340 [TBL] [Abstract][Full Text] [Related]
9. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment. Raghav PK; Verma YK; Gangenahalli GU Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216 [TBL] [Abstract][Full Text] [Related]
10. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis. Rajan S; Choi M; Baek K; Yoon HS Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960 [TBL] [Abstract][Full Text] [Related]
11. Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity. Anantram A; Kundaikar H; Degani M; Prabhu A J Biomol Struct Dyn; 2019 Aug; 37(12):3109-3121. PubMed ID: 30526410 [TBL] [Abstract][Full Text] [Related]
12. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins. Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548 [TBL] [Abstract][Full Text] [Related]
14. Modeling the Binding of Anticancer Peptides and Mcl-1. Alhammadi SHA; Baby B; Antony P; Jobe A; Humaid RSM; Alhammadi FJA; Vijayan R Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928234 [TBL] [Abstract][Full Text] [Related]
15. Toward Understanding Mcl-1 Promiscuous and Specific Binding Mode. Fogha J; Marekha B; De Giorgi M; Voisin-Chiret AS; Rault S; Bureau R; Sopkova-de Oliveira Santos J J Chem Inf Model; 2017 Nov; 57(11):2885-2895. PubMed ID: 29016132 [TBL] [Abstract][Full Text] [Related]
16. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1. Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174 [TBL] [Abstract][Full Text] [Related]
17. Deciphering the crucial residues involved in heterodimerization of Bak peptide and anti-apoptotic proteins for apoptosis. Marimuthu P; Singaravelu K J Biomol Struct Dyn; 2018 May; 36(6):1637-1648. PubMed ID: 28511583 [TBL] [Abstract][Full Text] [Related]
18. Conformational changes in Bcl-2 pro-survival proteins determine their capacity to bind ligands. Lee EF; Czabotar PE; Yang H; Sleebs BE; Lessene G; Colman PM; Smith BJ; Fairlie WD J Biol Chem; 2009 Oct; 284(44):30508-17. PubMed ID: 19726685 [TBL] [Abstract][Full Text] [Related]
19. Interactions of pro-apoptotic BH3 proteins with anti-apoptotic Bcl-2 family proteins measured in live MCF-7 cells using FLIM FRET. Liu Q; Leber B; Andrews DW Cell Cycle; 2012 Oct; 11(19):3536-42. PubMed ID: 22895112 [TBL] [Abstract][Full Text] [Related]
20. Promiscuous and Selective: How Intrinsically Disordered BH3 Proteins Interact with Their Pro-survival Partner MCL-1. Dahal L; Kwan TOC; Hollins JJ; Clarke J J Mol Biol; 2018 Aug; 430(16):2468-2477. PubMed ID: 29654795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]